Literature DB >> 4236543

The value of fluorinated pyrimidines in advanced malignancy.

J J Fennelly, M X Fitzgerald.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4236543      PMCID: PMC2008345          DOI: 10.1038/bjc.1968.80

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  11 in total

1.  5-FLUOURACIL IN THE TREATMENT OF DISSEMINATED COLON AND RECTAL CARCINOMA.

Authors:  E C WATSON
Journal:  N Z Med J       Date:  1964-09

2.  Effect of 5-fluorouracil on the adrenalectomized animal.

Authors:  J B TIPTON; W J REGAN
Journal:  Surgery       Date:  1963-04       Impact factor: 3.982

3.  The McVay herniorrhaphy--a surgical principle in practice.

Authors:  J MCCAFFREY
Journal:  Med J Aust       Date:  1962-10-13       Impact factor: 7.738

4.  The role of 5-fluorouracil in malignant disease.

Authors:  B J KENNEDY; A THEOLOGIDES
Journal:  Ann Intern Med       Date:  1961-11       Impact factor: 25.391

5.  Fluorinated pyrimidines, a new class of tumour-inhibitory compounds.

Authors:  C HEIDELBERGER; N K CHAUDHURI; P DANNEBERG; D MOOREN; L GRIESBACH; R DUSCHINSKY; R J SCHNITZER; E PLEVEN; J SCHEINER
Journal:  Nature       Date:  1957-03-30       Impact factor: 49.962

6.  The comparative utilization of uracil-2-C14 by liver, intestinal mucosa, and Flexner-Jobling carcinoma in the rat.

Authors:  C HEIDELBERGER; K C LEIBMAN; E HARBERS; P M BHARGAVA
Journal:  Cancer Res       Date:  1957-06       Impact factor: 12.701

7.  Clinical studies with 5-fluorouracil.

Authors:  A R CURRERI; F J ANSFIELD; F A McIVER; H A WAISMAN; C HEIDELBERGER
Journal:  Cancer Res       Date:  1958-05       Impact factor: 12.701

8.  Chemotherapy of inoperable malignancy.

Authors:  J J Fennelly
Journal:  Br J Surg       Date:  1967-10       Impact factor: 6.939

9.  A controlled comparison of 5-fluoro-2'-deoxyuridine therapy administered by rapid intravenous injection and by continuous intravenous infusion.

Authors:  C G Moertel; R J Reitemeier; R G Hahn
Journal:  Cancer Res       Date:  1967-03       Impact factor: 12.701

10.  The clinical effects of prolonged intravenous infusion of 5-fluoro-2'-deoxyuridine.

Authors:  R D Sullivan; E Miller
Journal:  Cancer Res       Date:  1965-08       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.